Relief Therapeutics Holding (XSWX:RLF) Operating Cash Flow per Share : CHF-0.83 (TTM As of Jun. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Relief Therapeutics Holding Operating Cash Flow per Share?

Relief Therapeutics Holding's operating cash flow per share for the six months ended in Jun. 2024 was CHF-0.25. Relief Therapeutics Holding's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2024 was CHF-0.83.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 20.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -83.60% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -0.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Relief Therapeutics Holding's Operating Cash Flow per Share or its related term are showing as below:

XSWX:RLF' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -220.3 Med: -33.9 Max: 68.2
Current: 20.9

During the past 13 years, Relief Therapeutics Holding's highest 3-Year average Operating Cash Flow per Share Growth Rate was 68.20% per year. The lowest was -220.30% per year. And the median was -33.90% per year.

XSWX:RLF's 3-Year OCF Growth Rate is ranked better than
68.93% of 1194 companies
in the Biotechnology industry
Industry Median: 3.6 vs XSWX:RLF: 20.90

Relief Therapeutics Holding Operating Cash Flow per Share Historical Data

The historical data trend for Relief Therapeutics Holding's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relief Therapeutics Holding Operating Cash Flow per Share Chart

Relief Therapeutics Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.14

-3.03

-3.98

-2.28

-1.50

Relief Therapeutics Holding Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-1.42	-0.87	-0.94	-0.58	-0.25

Competitive Comparison of Relief Therapeutics Holding's Operating Cash Flow per Share

For the Biotechnology subindustry, Relief Therapeutics Holding's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Relief Therapeutics Holding's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Relief Therapeutics Holding's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Relief Therapeutics Holding's Price-to-Operating-Cash-Flow falls into.

Relief Therapeutics Holding Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Relief Therapeutics Holding's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-17.612	/	11.752
	=	-1.50

Relief Therapeutics Holding's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Jun. 2024 )	=	Cash Flow from Operations (Q: Jun. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2024 )
	=	-3.166	/	12.540
	=	-0.25

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-0.83

Relief Therapeutics Holding Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Relief Therapeutics Holding's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Relief Therapeutics Holding Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Relief Therapeutics Holding SA (XSWX:RLF) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

RLFTY:USA RLFTF:USA RLFz:UK 0QKQ:UK

Address

Avenue de Secheron 15, Geneva, CHE, 1202

Website

https://www.relieftherapeutics.com

Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Its pipeline includes various drug candidates in their different stages of development such as RLF-TD011, and RLF-100, among others. It also has commercial legacy products like Cambia, Setofilm, Voltadol, and Voltfast among others. Geographically the company generates a majority of its revenue from Europe (excluding Switzerland) and the rest from North America, Switzerland, and the rest of the world.

Relief Therapeutics Holding Headlines

No Headlines